Article
CAR T cells and T cells phenotype and function are impacted by glucocorticoid exposure with different magnitude.
Journal of translational medicine - 12 Mar 2024
Poiret Thomas, Vikberg Sara, Schoutrop Esther, Mattsson Jonas, Magalhaes Isabelle
Abstract excerpt
BACKGROUND: Chimeric antigen receptor (CAR) T cell therapy is associated with high risk of adverse events. Glucocorticoids (GCs) are cornerstone in the management of high-grade cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome (ICANS). Given the potentially deleterious effects of GCs on CAR T cells anti-tumor activity, increasing our understanding of GCs impact on CAR T...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
